Diagnosis and Management of Non- Alcoholic Fatty Liver Disease
Diagnosis and Management of Non- Alcoholic Fatty Liver Disease
Diagnosis and Management of Non- Alcoholic Fatty Liver Disease
SHOW LESS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Pioglitazone is Beneficial<br />
In NASH<br />
• RTC <strong>of</strong> patients with impaired glucose<br />
tolerance or T2DM with biopsy proven<br />
NASH<br />
• Pioglitazone 45mg daily for 48 weeks<br />
resulted in improved necroinflammation<br />
Belfort NEJM 2006
Change language